Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Genetic Disease

Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Last 

Arizona

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Gilbert Arizona 85296

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Mesa Arizona 85210

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Peoria Arizona 85381

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Peoria Arizona 85381

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

View More ▼

Phoenix Arizona 85014

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona 85020

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona

A Phase 2 clinical study for patients with Macular Degeneration

Phoenix Arizona 85014

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Phoenix Arizona 85020

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Tucson Arizona 85704

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Tucson Arizona 85710

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Tucson Arizona 85704-5614

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

California

Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

Bakersfield California

A clinical trial seeking patients for a research study for the treatment of Age-Related Macular Degeneration

Bakersfield California 93309

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Beverly Hills California

A clinical trial seeking patients for a research study for the treatment of Age-Related Macular Degeneration

View More ▼

Beverly Hills California 90211

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Beverly Hills California 90211

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Beverly Hills California 90211

Patients are needed to participate in a clinical research study of X-82 oral and ranibizumab (Lucentis) to evaluate Exudative Macular Degeneration

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Campbell California 95008

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Fresno California 93720

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Glendale California 91203

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

La Jolla California 92093

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

La Jolla California 92093

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Laguna Hills California 92653

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Loma Linda California 92354

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Los Angeles California 90095

A clinical research study of Microplasmin and Placebo control for the treatment of Macular Degeneration

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Dry Age Related Macular Degeneration

Los Angeles California 90095

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Los Angeles California 90095

A clinical trial to evaluate treatments using MA09-hRPE Cellular therapy for patients with Stargardt's Macular Dystrophy

Marietta California 30060

A clinical trial to evaluate treatments using pegaptanib sodium injection for patients with Age-Related Macular Degeneration, Retinal Vein Occlusion or Diabetic Macular Edema

Mountain View California 94040

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Mountain View California 94040

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Mountain View California 94040

Patients are needed to participate in a clinical research study evaluating Ranibizumab for the treatment of Recalcitrant Wet Age-related Macular Degeneration

New Albany California 47150

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Palm Desert California 92211

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Pasadena California 91105-3153

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Sacramento California 95819

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Sacramento California 95841

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Sacramento California 95819

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Sacramento California 95819

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.